Article

Adjuvant chemotherapy for poor-responders to neoadjuvant therapy in locally advanced rectal cancer: does it improve the prognosis?

2021-02-24

Abstract excerpt

<h4>Background: </h4> Colorectal cancer is the first cause of cancer death in developed countries. Although colon and rectal cancers are frequently grouped as a single disease entity, these malignancies have important differences in treatment approaches ; The preoperative radio-chemotherapy combination has become the standard for tumors of the middle and lower rectum, improving local control. But unlike colon canc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fe28895f-902f-5816-9c34-720614346701
DOI: 10.21203/rs.3.rs-215233/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Adjuvant chemotherapy for poor-responders to neoadjuvant therapy in locally advanced rectal cancer: does it improve the prognosis?DOI 10.21203/rs.3.rs-215233/v1Read

Factors Affecting Survival Prognosis of Patients with Rectal Cancer After Neoadjuvant ChemoradiotherapySemantic proximity Read

Tumor Resectability and Pathologic Response After Neoadjuvant Long-Course Chemoradiotherapy for Locally Advanced Rectal Cancer in a Resource-Limited SettingSemantic proximity Read

Pathological Response Has Survival Benefits for Rectal Cancer following Neoadjuvant TherapySemantic proximity Read

An Integrated Model of Pathological Complete Response and Postoperative CEA Predicts Survival and Benefit of Adjuvant Chemotherapy for Locally Advanced Rectal CancerSemantic proximity Read

Rare but Marvelous Efficacy of Neoadjuvant Chemotherapy for Adenocarcinoma of Rectum: A Case ReportSemantic proximity Read

Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: A case report and literature review.Semantic proximity Read

Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancerSemantic proximity Read

Local Tuning of Radiomics-Based Model for Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerSemantic proximity Read

Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal Cancer Patients with BRAF Mutation: Clinical Benefit and Safety.Semantic proximity Read

Extensive multimodal treatments with Total Neoadjuvant Therapy followed by Total Mesorectal Excision for locally advanced rectal cancer allows fit older patients to achieve good oncologic and functional outcomes. Real world data and proof of conceptSemantic proximity Read

Evaluating the Benefits of Tegafur-Uracil Adjuvant Therapy in Low-Risk Stage IIa Colon Cancer: Insights from a Decade-Long StudySemantic proximity Read

Total Neoadjuvant Therapy and Organ Preservation in Locally Advanced Rectal Cancer: A State-of-the-Art Systematic Review and Critical AppraisalSemantic proximity Read